Wednesday, August 10, 2022 1:28:58 AM
There is some talk that perhaps they overhedged and this resulted in a big loss for Q2. I don't think that's the case as they hedged (only) 50% of production. They just got the timing wrong in Q2/April.
Two, they decided to give guidance now "in line with industry standards" which excludes earnings and revenues due to volatile pricing.
BS. That is what I said after they gave guidance in Q1. They should have seen this coming earlier but they decided to pump the pps anyway back then.
These are 2 serious management issues we are dealing with.
Also, they decided not to hedge for Q4 / going forward. So they clearly have a wobbly strategy on this.
On the bright side, due to prices coming down in Q3 so far, as things are now, they will book a gain of $23M gain from hedging. So Q3 could be a surprise to the upside. The market doesn't like surprises though!
All of this combined (especially with the poor management decisions) makes it really hard to say how much value there is (remaining) in this stock. They are newbies in the refining space, I guess. And they clearly made some serious mistakes.
---
Recent BDCO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 08:13:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:22:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:49:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:23:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 02:09:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 07:26:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 05:45:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2023 06:56:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2023 09:19:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 11:15:12 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:05:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM